{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:12:08Z","timestamp":1791756728236,"version":"4.3.4"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["# AI-047790"],"award-info":[{"award-number":["# AI-047790"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI-059623"],"award-info":[{"award-number":["AI-059623"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AT-004321"],"award-info":[{"award-number":["AT-004321"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000980","name":"Arthritis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.cyto.2017.04.012","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T13:01:01Z","timestamp":1493125261000},"page":"87-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"special_numbering":"C","title":["Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines"],"prefix":"10.1016","volume":"98","author":[{"given":"Eugene Y.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal D.","family":"Moudgil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.cyto.2017.04.012_b0010","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJM199005033221805","article-title":"Rheumatoid arthritis. Pathophysiology and implications for therapy","volume":"322","author":"Harris","year":"1990","journal-title":"N Engl. J. Med."},{"issue":"6","key":"10.1016\/j.cyto.2017.04.012_b0015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"5 Suppl 31","key":"10.1016\/j.cyto.2017.04.012_b0020","first-page":"S20","article-title":"Joint damage and disability in rheumatoid arthritis: an updated systematic review","volume":"21","author":"Scott","year":"2003","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0005","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/ar2936","article-title":"Interleukin-17A upregulates receptor activator of NF-kappaB on osteoclast precursors","volume":"12","author":"Adamopoulos","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.cyto.2017.04.012_b0025","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/BOR.0000000000000036","article-title":"T cell subsets and their role in the pathogenesis of rheumatic disease","volume":"26","author":"Gizinski","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2017.04.012_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2008.07.008","article-title":"Regulation of autoimmune inflammation by pro-inflammatory cytokines","volume":"120","author":"Kim","year":"2008","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2017.04.012_b0035","first-page":"3","article-title":"The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation","volume":"65","author":"Bingham","year":"2002","journal-title":"J. Rheumatol."},{"issue":"11","key":"10.1016\/j.cyto.2017.04.012_b0040","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1172\/JCI36389","article-title":"Evidence that cytokines play a role in rheumatoid arthritis","volume":"118","author":"Brennan","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cyto.2017.04.012_b0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.immunol.19.1.163","article-title":"Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?","volume":"19","author":"Feldmann","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2017.04.012_b0050","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1146\/annurev.iy.07.040189.003205","article-title":"The biology of cachectin\/TNF \u2013 a primary mediator of the host response","volume":"7","author":"Beutler","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2017.04.012_b0055","first-page":"97","article-title":"IFN-gamma: recent advances in understanding regulation of expression, biological functions, and clinical applications","volume":"316","author":"Young","year":"2007","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.cyto.2017.04.012_b0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon-like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0065","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.immuni.2014.09.006","article-title":"Innate lymphoid cells in inflammation and immunity","volume":"41","author":"McKenzie","year":"2014","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.cyto.2017.04.012_b0070","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/art.1780311012","article-title":"Treatment with gamma-interferon triggers the onset of collagen arthritis in mice","volume":"31","author":"Mauritz","year":"1988","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.cyto.2017.04.012_b0075","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/ar2477","article-title":"TH-17 cells in rheumatoid arthritis","volume":"10","author":"Shahrara","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.cyto.2017.04.012_b0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","article-title":"Evidence for a cross-talk between human neutrophils and Th17 cells","volume":"115","author":"Pelletier","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.30093","article-title":"Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production","volume":"63","author":"van Hamburg","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.cyto.2017.04.012_b0090","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1093\/rheumatology\/keu171","article-title":"CD70-expressing CD4 T cells produce IFN-gamma and IL-17 in rheumatoid arthritis","volume":"53","author":"Park","year":"2014","journal-title":"Rheumatology (Oxford, England)"},{"issue":"6","key":"10.1016\/j.cyto.2017.04.012_b0095","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3109\/s10165-012-0811-x","article-title":"The roles of IFN-gamma versus IL-17 in pathogenic effects of human Th17 cells on synovial fibroblasts","volume":"23","author":"Kato","year":"2013","journal-title":"Mod. Rheumatol."},{"issue":"4","key":"10.1016\/j.cyto.2017.04.012_b0100","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.22453","article-title":"Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17","volume":"56","author":"Chu","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.cyto.2017.04.012_b0105","doi-asserted-by":"crossref","first-page":"R158","DOI":"10.1186\/ar2838","article-title":"Regulation of pathogenic IL-17 responses in collagen-induced arthritis: roles of endogenous interferon-gamma and IL-4","volume":"11","author":"Sarkar","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/art.33335","article-title":"Overexpression of T-bet gene regulates murine autoimmune arthritis","volume":"64","author":"Kondo","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2017.04.012_b0115","doi-asserted-by":"crossref","first-page":"7464","DOI":"10.1038\/ncomms8464","article-title":"IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2(+)Vgamma6(+)gammadelta T cells","volume":"6","author":"Akitsu","year":"2015","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.cyto.2017.04.012_b0120","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1089\/jir.2011.0094","article-title":"A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis","volume":"31","author":"Astry","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"issue":"8","key":"10.1016\/j.cyto.2017.04.012_b0125","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.4049\/jimmunol.179.8.5576","article-title":"Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells","volume":"179","author":"Roark","year":"2007","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2017.04.012_b0130","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.ajpath.2015.03.012","article-title":"Tertiary Lymphoid Structures in Rheumatoid Arthritis: NF-kappaB-Inducing Kinase-Positive Endothelial Cells as Central Players","volume":"185","author":"Noort","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.cyto.2017.04.012_b0135","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nm.3892","article-title":"Innate lymphoid cells in the initiation, regulation and resolution of inflammation","volume":"21","author":"Sonnenberg","year":"2015","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cyto.2017.04.012_b0140","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.4049\/jimmunol.0903271","article-title":"IL-17 contributes to angiogenesis in rheumatoid arthritis","volume":"184","author":"Pickens","year":"2010","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2017.04.012_b0145","first-page":"625","article-title":"Therapy: Paradoxical effects of targeting TNF signalling in the treatment of autoimmunity","volume":"12","author":"Chen","year":"2016","journal-title":"Nat. Rev."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1189\/jlb.0204065","article-title":"Interleukin-17 regulates expression of the CXC chemokine LIX\/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment","volume":"76","author":"Ruddy","year":"2004","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10067-005-1081-1","article-title":"IL-17 increased the production of vascular endothelial growth factor in rheumatoid arthritis synoviocytes","volume":"25","author":"Ryu","year":"2006","journal-title":"Clin. Rheumatol."},{"issue":"13","key":"10.1016\/j.cyto.2017.04.012_b0160","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1002\/j.1460-2075.1991.tb04978.x","article-title":"Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis","volume":"10","author":"Keffer","year":"1991","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0165","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(00)80038-2","article-title":"Impaired on\/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies","volume":"10","author":"Kontoyiannis","year":"1999","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1084\/jem.20040435","article-title":"Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases","volume":"200","author":"Xanthoulea","year":"2004","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cyto.2017.04.012_b0175","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/1753425912470470","article-title":"Negative feedback on IL-23 exerted by IL-17A during pulmonary inflammation","volume":"19","author":"Silverpil","year":"2013","journal-title":"Innate. Immun."},{"issue":"4","key":"10.1016\/j.cyto.2017.04.012_b0180","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1074\/jbc.M110.187013","article-title":"Interleukin-27 and interferon-gamma are involved in regulation of autoimmune arthritis","volume":"286","author":"Rajaiah","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0185","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.clim.2008.01.003","article-title":"Regulation of autoimmune arthritis by the pro-inflammatory cytokine interferon-gamma","volume":"127","author":"Kim","year":"2008","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0190","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/ar2393","article-title":"Exogenous tumour necrosis factor alpha induces suppression of autoimmune arthritis","volume":"10","author":"Kim","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0195","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol. Today"},{"issue":"6","key":"10.1016\/j.cyto.2017.04.012_b0200","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0167-5699(97)80019-9","article-title":"The Th1\/Th2 paradigm","volume":"18","author":"Romagnani","year":"1997","journal-title":"Immunol. Today"},{"issue":"7090","key":"10.1016\/j.cyto.2017.04.012_b0205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cyto.2017.04.012_b0210","first-page":"717","article-title":"Temporal cytokine expression and the target organ attributes unravel novel aspects of autoimmune arthritis","volume":"138","author":"Astry","year":"2013","journal-title":"Indian J. Med. Res."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2015.05.006","article-title":"Interplay among cytokines and T cell subsets in the progression and control of immune-mediated diseases","volume":"74","author":"Moudgil","year":"2015","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/08916931003782155","article-title":"Natural regulatory T cells in autoimmunity","volume":"44","author":"Lourenco","year":"2011","journal-title":"Autoimmunity"},{"issue":"8","key":"10.1016\/j.cyto.2017.04.012_b0225","first-page":"1466","article-title":"Analysis of type 1 and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis","volume":"25","author":"Kusaba","year":"1998","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0230","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/rheumatology\/38.3.214","article-title":"Quantitation of interferon gamma- and interleukin-4-producing T cells in synovial fluid and peripheral blood of arthritis patients","volume":"38","author":"van der Graaff","year":"1999","journal-title":"Rheumatology (Oxford, England)"},{"issue":"5","key":"10.1016\/j.cyto.2017.04.012_b0235","first-page":"1128","article-title":"Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry","volume":"27","author":"Berner","year":"2000","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.cyto.2017.04.012_b0240","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/art.27622","article-title":"Role of Th17 cells in human autoimmune arthritis","volume":"62","author":"Leipe","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0245","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/art.23291","article-title":"Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers","volume":"58","author":"Nistala","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"33","key":"10.1016\/j.cyto.2017.04.012_b0250","doi-asserted-by":"crossref","first-page":"14751","DOI":"10.1073\/pnas.1003852107","article-title":"Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment","volume":"107","author":"Nistala","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.cyto.2017.04.012_b0255","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2013.10.009","article-title":"The plasticity of human Treg and Th17 cells and its role in autoimmunity","volume":"25","author":"Kleinewietfeld","year":"2013","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0260","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.immuni.2008.12.009","article-title":"Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells","volume":"30","author":"Wei","year":"2009","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0265","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.immuni.2015.02.003","article-title":"Retinoic acid is essential for Th1 cell lineage stability and prevents transition to a Th17 cell program","volume":"42","author":"Brown","year":"2015","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.cyto.2017.04.012_b0270","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.4049\/jimmunol.172.5.2795","article-title":"The T cells specific for the carboxyl-terminal determinants of self (rat) heat-shock protein 65 escape tolerance induction and are involved in regulation of autoimmune arthritis","volume":"172","author":"Durai","year":"2004","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2017.04.012_b0275","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.185.7.1307","article-title":"Diversification of T cell responses to carboxy-terminal determinants within the 65-kD heat-shock protein is involved in regulation of autoimmune arthritis","volume":"185","author":"Moudgil","year":"1997","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0280","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4049\/jimmunol.173.1.181","article-title":"The regulatory C-terminal determinants within mycobacterial heat shock protein 65 are cryptic and cross-reactive with the dominant self homologs: implications for the pathogenesis of autoimmune arthritis","volume":"173","author":"Durai","year":"2004","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0285","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/ar2430","article-title":"Paradoxical effects of tumour necrosis factor-alpha in adjuvant-induced arthritis","volume":"10","author":"Williams","year":"2008","journal-title":"Arthritis research & therapy"},{"issue":"2","key":"10.1016\/j.cyto.2017.04.012_b0290","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","article-title":"A brief history of T(H)17, the first major revision in the T(H)1\/T(H)2 hypothesis of T cell-mediated tissue damage","volume":"13","author":"Steinman","year":"2007","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.cyto.2017.04.012_b0295","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.20071258","article-title":"Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category","volume":"205","author":"Luger","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2017.04.012_b0300","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev.iy.08.040190.003051","article-title":"The T lymphocyte in experimental allergic encephalomyelitis","volume":"8","author":"Zamvil","year":"1990","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0305","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cyto.2014.10.014","article-title":"Interferon gammainautoimmunity: A complicated player on a complex stage","volume":"74","author":"Lees","year":"2015","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cyto.2017.04.012_b0310","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1172\/JCI29571","article-title":"The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage","volume":"117","author":"Lin","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.cyto.2017.04.012_b0315","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.189.2.219","article-title":"Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis","volume":"189","author":"Tarrant","year":"1999","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0320","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/art.24139","article-title":"Tolerization with Hsp65 induces protection against adjuvant-induced arthritis by modulating the antigen-directed interferon-gamma, interleukin-17, and antibody responses","volume":"60","author":"Satpute","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"1\u20132","key":"10.1016\/j.cyto.2017.04.012_b0325","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01993239","article-title":"The effect of treatment with recombinant gamma-interferon on adjuvant-induced arthritis in rats","volume":"34","author":"Nakajima","year":"1991","journal-title":"Agents Actions"},{"issue":"2","key":"10.1016\/j.cyto.2017.04.012_b0330","first-page":"245","article-title":"Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibody","volume":"78","author":"Wiesenberg","year":"1989","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2017.04.012_b0335","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1440-1711.2005.01313.x","article-title":"Blockade of IFN-gamma does not affect the arthritogenicity of T cells generated during the induction of adjuvant arthritis but exacerbates the polyarthritis produced by adoptive transfer of arthritogenic effector cells","volume":"83","author":"Brasted","year":"2005","journal-title":"Immunol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.cyto.2017.04.012_b0340","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.4049\/jimmunol.169.6.3422","article-title":"Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60","volume":"169","author":"Quintana","year":"2002","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2017.04.012_b0345","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/1529-0131(200110)44:10<2413::AID-ART406>3.0.CO;2-E","article-title":"Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain","volume":"44","author":"Guedez","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.cyto.2017.04.012_b0350","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.4049\/jimmunol.158.11.5507","article-title":"Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice","volume":"158","author":"Vermeire","year":"1997","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0355","doi-asserted-by":"crossref","first-page":"R220","DOI":"10.1186\/ar1167","article-title":"Enhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesis","volume":"6","author":"De Klerck","year":"2004","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.cyto.2017.04.012_b0360","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar2787","article-title":"Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma","volume":"11","author":"Kelchtermans","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0365","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.4049\/jimmunol.0902907","article-title":"IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis","volume":"184","author":"Doodes","year":"2010","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2017.04.012_b0370","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/ar432","article-title":"Paradoxical roles of IFN-gamma in models of Th1-mediated autoimmunity","volume":"4","author":"Rosloniec","year":"2002","journal-title":"Arthritis Res."},{"issue":"10","key":"10.1016\/j.cyto.2017.04.012_b0375","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.4049\/jimmunol.163.10.5278","article-title":"IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide","volume":"163","author":"Willenborg","year":"1999","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0380","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.4049\/jimmunol.167.3.1821","article-title":"Intrathecal delivery of IFN-gamma protects C57BL\/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes","volume":"167","author":"Furlan","year":"2001","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2017.04.012_b0385","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.4049\/jimmunol.170.11.5491","article-title":"IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma","volume":"170","author":"Trembleau","year":"2003","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2017.04.012_b0390","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/intimm\/dxh173","article-title":"In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma\/TNF-alpha","volume":"16","author":"Qin","year":"2004","journal-title":"Int. Immunol."},{"issue":"25","key":"10.1016\/j.cyto.2017.04.012_b0395","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1161\/hc5001.100629","article-title":"Interleukin-12 receptor\/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway","volume":"104","author":"Afanasyeva","year":"2001","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.cyto.2017.04.012_b0400","doi-asserted-by":"crossref","first-page":"11495","DOI":"10.1073\/pnas.1002099107","article-title":"Identification of an IL-27\/osteopontin axis in dendritic cells and its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation","volume":"107","author":"Murugaiyan","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.cyto.2017.04.012_b0405","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.20141678","article-title":"NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-gamma-IL-27 axis","volume":"212","author":"Chong","year":"2015","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0410","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1177\/0394632015595757","article-title":"Altered Th17\/Treg balance and dysregulated IL-1beta response influence susceptibility\/resistance to experimental autoimmune arthritis","volume":"28","author":"Venkatesha","year":"2015","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"2","key":"10.1016\/j.cyto.2017.04.012_b0415","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4049\/jimmunol.180.2.922","article-title":"IL-27 induces a Th1 immune response and susceptibility to experimental arthritis","volume":"180","author":"Cao","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2017.04.012_b0420","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/art.39811","article-title":"Altered Innate Lymphoid Cells subsets in human lymph node biopsies during the at risk and earliest phase of rheumatoid arthritis","volume":"69","author":"Rodriguez-Carrio","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"9","key":"10.1016\/j.cyto.2017.04.012_b0425","first-page":"2434","article-title":"Role of IFN-gamma in induction of Foxp3 and conversion of CD4+ CD25- T cells to CD4+ Tregs","volume":"116","author":"Wang","year":"2006","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.cyto.2017.04.012_b0430","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.it.2006.02.008","article-title":"Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo","volume":"27","author":"Wood","year":"2006","journal-title":"Trends Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2017.04.012_b0435","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1053\/j.gastro.2011.03.009","article-title":"Interleukin-12 converts Foxp3+ regulatory T cells to interferon-gamma-producing Foxp3+ T cells that inhibit colitis","volume":"140","author":"Feng","year":"2011","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cyto.2017.04.012_b0440","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.4049\/jimmunol.1200413","article-title":"IFN-gamma production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease","volume":"189","author":"Koenecke","year":"2012","journal-title":"J. Immunol."},{"issue":"1 Suppl","key":"10.1016\/j.cyto.2017.04.012_b0445","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/01.tp.0000269115.60728.b1","article-title":"Interferon gamma: friend or foe?","volume":"84","author":"Wood","year":"2007","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cyto.2017.04.012_b0450","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.imbio.2016.09.012","article-title":"IFN-gamma-producing Th1-like regulatory T cells may limit acute cellular renal allograft rejection: Paradoxical post-transplantation effects of IFN-gamma","volume":"222","author":"Xu","year":"2017","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.cyto.2017.04.012_b0455","doi-asserted-by":"crossref","first-page":"R402","DOI":"10.1186\/ar1500","article-title":"Defective CD4+ CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma","volume":"7","author":"Kelchtermans","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0460","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/BF00919974","article-title":"Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on fibroblast-like synoviocytes: paradoxical induction of IFN-gamma and TNF-alpha receptor expression","volume":"13","author":"Alvaro-Gracia","year":"1993","journal-title":"J. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2017.04.012_b0465","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1002\/art.22732","article-title":"Interferon-gamma protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints","volume":"56","author":"Williams","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.cyto.2017.04.012_b0470","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/eji.200838170","article-title":"Mutual antagonistic relationship between prostaglandin E(2) and IFN-gamma: Implications for rheumatoid arthritis","volume":"38","author":"Mathieu","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2017.04.012_b0475","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.4049\/jimmunol.181.7.5089","article-title":"Lipopolysaccharide-induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-gamma via superinduction of ATF-3 and suppression of AP-1","volume":"181","author":"Ho","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2017.04.012_b0480","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/ar2960","article-title":"Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis","volume":"12","author":"Page","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2009.11.021","article-title":"Gene modulation and immunoregulatory roles of interferon gamma","volume":"50","author":"Saha","year":"2010","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.cyto.2017.04.012_b0490","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF00271840","article-title":"Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma","volume":"8","author":"Lemmel","year":"1988","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.cyto.2017.04.012_b0495","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00302149","article-title":"Double blind controlled phase III multicenter clinical trial with interferon gamma in rheumatoid arthritis","volume":"12","author":"Hofschneider","year":"1992","journal-title":"German Lymphokine Study Group, Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0500","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/art.1780400110","article-title":"A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis","volume":"40","author":"Veys","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.cyto.2017.04.012_b0505","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/anr.1780320805","article-title":"Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis","volume":"32","author":"Cannon","year":"1989","journal-title":"Arthritis Rheum."},{"issue":"46","key":"10.1016\/j.cyto.2017.04.012_b0510","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1055\/s-2008-1069083","article-title":"Interferon in chronic polyarthritis. Positive effect in clinical evaluation","volume":"110","author":"Obert","year":"1985","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"35","key":"10.1016\/j.cyto.2017.04.012_b0515","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1055\/s-2008-1068626","article-title":"Gamma interferon in psoriatic arthritis","volume":"111","author":"Fierlbeck","year":"1986","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0520","first-page":"93","article-title":"Use of recombinant human gamma interferon in patients with rheumatoid arthritis","volume":"45","author":"Seitz","year":"1986","journal-title":"Z. Rheumatol."},{"issue":"9","key":"10.1016\/j.cyto.2017.04.012_b0525","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0530","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","article-title":"Tumor necrosis factor signaling","volume":"10","author":"Wajant","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cyto.2017.04.012_b0535","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000289205","article-title":"The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions","volume":"11","author":"Sfikakis","year":"2010","journal-title":"Current Dir. Autoimmun."},{"issue":"5","key":"10.1016\/j.cyto.2017.04.012_b0540","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-4632.2011.04871.x","article-title":"TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists","volume":"50","author":"Williams","year":"2011","journal-title":"Int. J. Dermatol."},{"issue":"2","key":"10.1016\/j.cyto.2017.04.012_b0545","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/art.27203","article-title":"Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells","volume":"62","author":"Ma","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"6154","key":"10.1016\/j.cyto.2017.04.012_b0550","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/331356a0","article-title":"Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis","volume":"331","author":"Jacob","year":"1988","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0555","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.180.3.995","article-title":"Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process","volume":"180","author":"Yang","year":"1994","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.cyto.2017.04.012_b0560","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.4049\/jimmunol.1003868","article-title":"Natural but not inducible regulatory T cells require TNF-alpha signaling for in vivo function","volume":"186","author":"Housley","year":"2011","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2017.04.012_b0565","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1084\/jem.20151255","article-title":"Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis","volume":"213","author":"Nguyen","year":"2016","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0570","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","article-title":"Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells","volume":"179","author":"Chen","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0575","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4049\/jimmunol.1202659","article-title":"TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment","volume":"190","author":"Chen","year":"2013","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2017.04.012_b0580","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/carcin\/bgt038","article-title":"Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis","volume":"34","author":"Chopra","year":"2013","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0585","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nm.4019","article-title":"Suppressive activity of human regulatory T cells is maintained in the presence of TNF","volume":"22","author":"Zaragoza","year":"2016","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.cyto.2017.04.012_b0590","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.4049\/jimmunol.0902070","article-title":"TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function","volume":"184","author":"Nagar","year":"2010","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0595","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nm.3085","article-title":"Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis","volume":"19","author":"Nie","year":"2013","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0600","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1182\/blood-2005-11-4567","article-title":"TNF downmodulates the function of human CD4+CD25hi T-regulatory cells","volume":"108","author":"Valencia","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cyto.2017.04.012_b0605","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.4049\/jimmunol.175.8.5024","article-title":"Paradoxical anti-inflammatory actions of TNF-alpha: inhibition of IL-12 and IL-23 via TNF receptor 1 in macrophages and dendritic cells","volume":"175","author":"Zakharova","year":"2005","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2017.04.012_b0610","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4161\/cc.2.6.566","article-title":"Death receptor activation complexes: it takes two to activate TNF receptor 1","volume":"2","author":"Sheikh","year":"2003","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.cyto.2017.04.012_b0615","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s10875-015-0182-0","article-title":"Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response","volume":"35","author":"Talotta","year":"2015","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0620","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/cei.12626","article-title":"Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis","volume":"181","author":"Hull","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.cyto.2017.04.012_b0625","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1084\/jem.20072707","article-title":"Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells","volume":"205","author":"Notley","year":"2008","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0630","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/cei.12209","article-title":"Blockade of tumour necrosis factor-alpha in experimental autoimmune encephalomyelitis reveals differential effects on the antigen-specific immune response and central nervous system histopathology","volume":"175","author":"Batoulis","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2017.04.012_b0635","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(96)00183-X","article-title":"TNF-alpha receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview","volume":"72","author":"Klinkert","year":"1997","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.cyto.2017.04.012_b0640","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1002\/eji.1830270822","article-title":"Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system","volume":"27","author":"Korner","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0645","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/cimm.2000.1706","article-title":"Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35\u201355)-induced experimental autoimmune encephalomyelitis","volume":"205","author":"Suvannavejh","year":"2000","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cyto.2017.04.012_b0650","first-page":"671935","article-title":"Demyelinating disease following anti-TNFa Treatment: a causal or coincidental association?","volume":"2013","author":"Andreadou","year":"2013","journal-title":"Report of Four Cases and Rev. Literature, Case reports in Neurol. Med."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0655","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/1529-0131(200101)44:1<61::AID-ANR9>3.0.CO;2-Q","article-title":"Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I","volume":"44","author":"Barton","year":"2001","journal-title":"Caucasians, Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.cyto.2017.04.012_b0660","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/art.10101","article-title":"European Consortium on Rheumatoid Arthritis, Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: evidence for genetic heterogeneity","volume":"46","author":"Dieude","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.cyto.2017.04.012_b0665","first-page":"443","article-title":"TNF microsatellites polymorphism is associated with rheumatoid arthritis","volume":"25","author":"Gomez","year":"2007","journal-title":"Confirming Evidence in Northwestern Colombians, Clin. Ex. Rheumatol."},{"issue":"4","key":"10.1016\/j.cyto.2017.04.012_b0670","first-page":"645","article-title":"The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis","volume":"27","author":"Chatzikyriakidou","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"issue":"10","key":"10.1016\/j.cyto.2017.04.012_b0675","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/art.38755","article-title":"Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis","volume":"66","author":"McCann","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.cyto.2017.04.012_b0680","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.4049\/jimmunol.180.10.6467","article-title":"Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells","volume":"180","author":"Chen","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2017.04.012_b0685","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4049\/jimmunol.0903548","article-title":"Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells","volume":"185","author":"Chen","year":"2010","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2017.04.012_b0690","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1182\/blood-2016-04-711275","article-title":"TNF-alpha priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment","volume":"128","author":"Pierini","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cyto.2017.04.012_b0695","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.4049\/jimmunol.174.11.6993","article-title":"Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells","volume":"174","author":"Ochando","year":"2005","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.cyto.2017.04.012_b0700","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1002\/art.34565","article-title":"Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy","volume":"64","author":"McGovern","year":"2012","journal-title":"Arthritis Rheum."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617300972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466617300972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T08:02:18Z","timestamp":1692777738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466617300972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":140,"alternative-id":["S1043466617300972"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2017.04.012","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2017.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}